OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acquired and intrinsic gemcitabine resistance in pancreatic cancer therapy: Environmental factors, molecular profile and drug/nanotherapeutic approaches
Milad Ashrafizadeh, Kuo Luo, Wei Zhang, et al.
Environmental Research (2023) Vol. 240, pp. 117443-117443
Closed Access | Times Cited: 15

Showing 15 citing articles:

Hypoxia-associated autophagy flux dysregulation in human cancers
Jiding Fu, Jie Lin, Zili Dai, et al.
Cancer Letters (2024) Vol. 590, pp. 216823-216823
Closed Access | Times Cited: 8

Investigating autophagy and intricate cellular mechanisms in hepatocellular carcinoma: Emphasis on cell death mechanism crosstalk
Gang Wang, Xiaodi Jiang, Pedram Torabian, et al.
Cancer Letters (2024) Vol. 588, pp. 216744-216744
Open Access | Times Cited: 5

A review on L-methioninase in cancer therapy: Precision targeting, advancements and diverse applications for a promising future
Bhumi M. Javia, Megha S. Gadhvi, Suhas Vyas, et al.
International Journal of Biological Macromolecules (2024) Vol. 265, pp. 130997-130997
Closed Access | Times Cited: 5

Designing functionalized nanodiamonds with hyaluronic acid–phospholipid conjugates for enhanced cancer cell targeting and fluorescence imaging capabilities
Sofia Sturari, Ilaria Andreana, Pietro Aprà, et al.
Nanoscale (2024) Vol. 16, Iss. 24, pp. 11610-11622
Open Access | Times Cited: 3

YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer
Borui Li, Faliang Xing, Jingyi Wang, et al.
Cancer Letters (2024) Vol. 602, pp. 217197-217197
Open Access | Times Cited: 3

Drug-repurposing by virtual and experimental screening of PFKFB3 inhibitors for pancreatic cancer therapy
Xin Cao, Xiao Jiang, Zhi-Xin Zhong, et al.
European Journal of Pharmacology (2024) Vol. 965, pp. 176330-176330
Closed Access | Times Cited: 1

Pancreatic cancer cells exchange ribosomes through tunneling nanotubes
Stanislava Martínková, Denisa Jansová, Jana Vorel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Deciphering the role of Enterococcus faecium cytidine deaminase in gemcitabine resistance of gallbladder cancer
Lin Jiang, Lingxiao Zhang, Yijun Shu, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 4, pp. 107171-107171
Open Access

Human Equilibrative Nucleoside Transporter 1: Novel Biomarker and Prognostic Indicator for Patients with Gemcitabine-Treated Pancreatic Cancer
Jianchun Xiao, Fangyu Zhao, Wenhao Luo, et al.
Cancer Management and Research (2024) Vol. Volume 16, pp. 651-661
Open Access

Establishment of a prognostic model for pancreatic cancer based on vesicle-mediated transport protein-related genes
Yanfang Cao, Renwei Xing, Fan Yang, et al.
Computer Methods in Biomechanics & Biomedical Engineering (2024), pp. 1-11
Closed Access

The role of autophagy in pancreatic diseases
Wengang Zhang, Qing-Zhen Wu, Bo‐Zong Shao
Frontiers in Pharmacology (2024) Vol. 15
Open Access

Apolipoprotein B/Apolipoprotein A1 ratio is an independent prognostic factor in pancreatic cancer
Chenxi Li, Xuhui Yang, Yan Zhong, et al.
Translational Oncology (2024) Vol. 51, pp. 102208-102208
Closed Access

Baicalein, a natural flavonoid in gastrointestinal cancers treatment: recent trends and future perspectives
Añil Sharma, Deeksha Pal, Anita Rani Gill, et al.
Medical Oncology (2024) Vol. 42, Iss. 1
Closed Access

Page 1

Scroll to top